ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48526 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48526; 2) Community: the network communities that were significantly associated with the response to NSC 48526; 3) Molecule: the relationships between components within communities and NSC 48526; 4) MDR: the compounds that were significantly associated with the NSC 48526.

NSC Compound Enrichment Correlation
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0048681766467277 0.096294911
NSC 645265 Null 0.0048681766467277 0.12362851
NSC 656208 Null 0.0048681766467277 0.20687891
NSC 65921 Fluorene, 9-bromo-2,4,7-trichloro- 0.0048681766467277 0.27622546
NSC 681637 Camptothecin Derivative 0.0048681766467277 0.16807576
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0048681766467277 0.13103057
NSC 707404 Null 0.0048681766467277 0.11851708
NSC 708822 Null 0.0048681766467277 0.23425758
NSC 709971 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- 0.0048681766467277 0.27562131
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0048681766467277 0.11022183
Total:77  Current:12    [First] [Prev] [Next] [Last]